These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11395792)

  • 1. [Biological monitoring: concepts and applications in public health].
    Pivetta F; Machado JM; Araújo UC; Moreira MF; Apostoli P
    Cad Saude Publica; 2001; 17(3):545-54. PubMed ID: 11395792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concepts and determination of reference values for human biomonitoring of environmental contaminants].
    Kuno R; Roquetti MH; Gouveia N
    Rev Panam Salud Publica; 2010 Jan; 27(1):74-9. PubMed ID: 20209235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values and action levels of biological monitoring in occupational exposure.
    Ong CN
    Toxicol Lett; 1999 Sep; 108(2-3):127-35. PubMed ID: 10511254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological monitoring guidance values for chemical incidents.
    Cocker J; Jones K; Bos PM
    Toxicol Lett; 2014 Dec; 231(3):324-7. PubMed ID: 24973493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomonitoring of exposure to chemical products in environmental and workplace toxicology].
    Mistretta V; Charlier C
    Ann Biol Clin (Paris); 2013; 71(3):257-67. PubMed ID: 23747663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring and medical screening at the workplace in the EC countries.
    Rasmussen K; Lunde-Jensen P; Svane O
    Int Arch Occup Environ Health; 1991; 63(5):347-52. PubMed ID: 1765412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perspective on biological monitoring guidance values.
    Cocker J
    Toxicol Lett; 2014 Dec; 231(2):122-5. PubMed ID: 25223251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics in biomonitoring for occupational health.
    Manno M; Sito F; Licciardi L
    Toxicol Lett; 2014 Dec; 231(2):111-21. PubMed ID: 25447455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Before the storm: informing and involving stakeholder groups in workplace biomarker monitoring.
    Musham C; Trettin L; Jablonski R
    J Public Health Policy; 1999; 20(3):319-34. PubMed ID: 10874405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Integration of biological and workplace monitoring as an efficient control of chemical exposure].
    Gelormini A; Barbaro M; Cidaria D; Dall'Olio M
    G Ital Med Lav Ergon; 2005; 27(3):329-31. PubMed ID: 16240587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring at the UK Health and Safety Laboratory.
    Cocker J; Jones K; Morton J; Mason HJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):383-6. PubMed ID: 17321210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framework for the development and application of environmental biological monitoring guidance values.
    Bevan R; Angerer J; Cocker J; Jones K; Koch HM; Sepai O; Schoeters G; Smolders R; Levy L
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):453-60. PubMed ID: 22683832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological exposure and/or effect limits, facts, fallacies, and uncertainties: practical aspects.
    Monster AC; Zielhuis RL
    J Soc Occup Med; 1991; 41(2):60-3. PubMed ID: 2051756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance values for the biomonitoring of occupational exposure. State of the art.
    Aitio A
    Med Lav; 2006; 97(2):324-31. PubMed ID: 17017366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biomonitoring programmes and activities in the European Union.
    Viso AC; Casteleyn L; Biot P; Eilstein D
    J Epidemiol Community Health; 2009 Aug; 63(8):623-4. PubMed ID: 19596843
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference values for the study of low doses.
    Alessio L
    Sci Total Environ; 1992 Jun; 120(1-2):1-6. PubMed ID: 1641628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems concerning the integration of "derived-no-effect-levels" (DNELS) into occupational safety and health regulations].
    Gromiec J
    Med Pr; 2008; 59(1):65-73. PubMed ID: 18663897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.